CHARITA JOHNSON: Open Payments
NPI 1942752076 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 34 payments from 8 companies in 2025. Trend: 2023 $410 · 2024 $314 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $223 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $194 |
| AstraZeneca Pharmaceuticals LP | 9 | $160 |
| ABBVIE INC. | 4 | $79 |
| Amgen Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: CAPLYTA, Ozempic, BREZTRI, VRAYLAR, FARXIGA, OTEZLA, TRELEGY ELLIPTA, Rybelsus.
Industry payments across SC — which companies pay providers there.
